News | News By Subject | News by Disease News By Date | Search News

Attention-Deficit Hyperactivity Disorder (ADHD) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Investors Gain Focus as Shire (SHPG) Stock Rises at Positive ADHD Drug News     6/30/2016
FDA Indicates Deficiencies in Neos Therapeutics (NEOS)’s ADHD New Drug Application     10/20/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Mallinckrodt Pharmaceuticals (MNK)'s Generic ADHD Drug Does Not Measure Up To Johnson & Johnson (JNJ)'s Concerta: FDA     11/14/2014
FDA Needs More Pediatric Data For Resubmission Of ADHD Drug: Shire     10/9/2014
Alcobra (ADHD)'s ADHD Drug Metadoxine Meets Goals In Late-Stage Study     10/6/2014
Supernus Pharmaceuticals (SUPN) Snags FDA Fast Track Designation For ADHD Drug SPN-810     8/15/2014
Theravance, Inc. (THRX) Abandons ADHD Drug After Drug Fails Phase 2 Study     11/15/2013
FDA Approves Shire plc's Vyvanse for Children With ADHD     5/2/2013
Shire plc Settles With Actavis (ACT), Watson Pharmaceuticals, Inc. (WPI) on ADHD Drug     4/25/2013
Shire plc ADHD Drug Elvanse Close to Europe Approval     12/19/2012
NextWave Pharmaceuticals Receives FDA Approval of Quillivant XR™ for Once-Daily Treatment of ADHD     10/1/2012
Targacept, Inc. (TRGT) to Cut More Jobs, Halt ADHD Drug Development After Failed Phase 2 Trial     9/18/2012

News from Around the Web
Unhealthy Diet During Pregnancy Could Be Linked To ADHD, University College London Study     8/19/2016
Acetaminophen During Pregnancy Could Cause ADHD, University of Bristol Study Finds     8/16/2016
Could We One Day Heal The Mind By Taking Control Of Our Dreams?     7/15/2016
Adults, Especially Women, May Develop ADHD Later In Life -- Or Else Were Missed As Kids, Published In JAMA Psychiatry     5/20/2016
Phthalates, Chemicals Used In Some Medical Devices, Could Be Creating Attention Deficit In Children, University of Antwerp Study     4/27/2016
Videogame Addiction Linked To ADHD, University Of Bergen Study     4/26/2016
Could A Brain "Growth Chart" Spot Attention Problems Early? University of Michigan Study Suggests     4/15/2016
Maternal Obesity Tied To Increase In Child Behavior Problems, University of Pittsburgh Study     3/25/2016
Childhood ADHD Doubles Obesity Risk In Women, Mayo Clinic Study Shows     2/5/2016
New Video Game Aims To Help Kids With ADHD, Akili Interactive Labs Reveals     1/25/2016
Technology Makes ADHD Better, Not Worse -- Part I     6/26/2015
How Drug Companies Benefit From Adult ADHD     6/23/2015
Common Pesticide Linked To ADHD In Boys, Cincinnati Children's Hospital Medical Center Study     6/4/2015
Workers Seeking Productivity In A Pill Are Abusing ADHD Drugs     4/23/2015
Kids With ADHD Must Squirm To Learn, University of Central Florida Study Says     4/20/2015

Press Releases
Neos Therapeutics (NEOS) Submits NDA For Amphetamine Extended-Release Liquid Suspension Drug Candidate, NT-0201, For The Treatment Of ADHD     11/17/2016
Medgenics, Inc. Presents New Data Showing Prevalence Of Genetic Mutations In Pediatric Populations With Attention Deficit Hyperactivity Disorder     10/31/2016
Ironshore Pharma Presents New Pivotal Trial Data At AACAP Meeting     10/28/2016
Children's Hospital of Philadelphia Release: New Study: Children With Autism May Be Over-Diagnosed With ADHD     10/27/2016
Investors Relieved as Supernus (SUPN) ADHD Drug Meets Goals in Phase IIb Study     10/11/2016
Update from Alcobra (ADHD) On Recent FDA Communications     10/7/2016
Ironshore Pharmaceuticals And CHADD To Raise Awareness About The Negative Impact Of ADHD During The Early Morning Routine     10/5/2016
FDA Slaps Clinical Hold on Alcobra (ADHD)'s Late Stage ADHD Study     9/29/2016
Sunovion Announces Results From Pivotal Study Evaluating Novel Drug Candidate Dasotraline In Children With ADHD     9/20/2016
Highland Therapeutics Announces Initiation Of Phase II Trial For HLD100 In Pediatric ADHD Patients     8/25/2016
Neurovance Announces Positive Centanafadine Phase 2b Results For Adult ADHD, And Plans For Phase 3 Trials     7/27/2016
Medgenics, Inc. Announces Enrollment Of First Patient In Phase 2/3 Clinical Trial Of NFC-1 In Adolescents With mGluR Mutation Positive ADHD     6/17/2016
NLS Pharma Release: FDA Accepts IND For Phase II Study Of Mazindol In Adults With ADHD     6/16/2016
Highland Therapeutics Announces Positive Data From Second Pivotal ADHD Trial For HLD-200     6/6/2016
Neos Therapeutics (NEOS) Announces U.S. Launch Of Adzenys XR-ODT (Amphetamine Extended-Release Orally Disintegrating Tablet) For The Treatment Of ADHD In Patients Six Years And Older     5/16/2016

//-->